What is 10x Genomics, Inc.'s Shariah compliance score?

10x Genomics, Inc. (TXG) has a Shariah compliance score of 82/100 (Grade: A, Very Good) based on AAOIFI screening standards. Scores above 70 typically indicate strong compliance. The score factors in business activity screening and financial ratio analysis including debt levels, interest-bearing deposits, and prohibited income percentages. View the full breakdown at HalalScreener.app.

Does 10x Genomics, Inc. pass AAOIFI screening?

10x Genomics, Inc. (TXG) passes AAOIFI Shariah screening. AAOIFI requires: (1) no primary involvement in prohibited activities like alcohol, gambling, or conventional banking, (2) debt-to-market-cap below 30% (TXG: 2.7%), (3) interest-bearing deposits below 30% (TXG: 4.6%), and (4) prohibited income below 5% (TXG: 2.4%). HalalScreener provides free AAOIFI screening for 10,000+ stocks at halalscreener.app.

How much purification is needed for 10x Genomics, Inc. stock?

10x Genomics, Inc. (TXG) has a non-permissible income ratio of 2.38%. Muslim investors should purify this percentage of any dividends received and capital gains realized from TXG shares by donating it to charity. HalalScreener's purification calculator at halalscreener.app/en/purification automates this calculation using the latest financial data.

Where can I screen 10x Genomics, Inc. for Shariah compliance for free?

HalalScreener (halalscreener.app) offers free Shariah compliance screening for 10x Genomics, Inc. (TXG) and 10,000+ other US-listed stocks, ETFs, and 100+ cryptocurrencies. The screening uses AAOIFI Standard No. 21 and shows all financial ratios transparently. No credit card or signup required for basic screening. HalalScreener also includes an AI Islamic Scholar for follow-up questions about TXG's compliance across different madhabs (Hanafi, Shafi'i, Maliki, Hanbali, Ja'fari).

TXG: Is 10x Genomics, Inc. Halal?

10x Genomics, Inc.

NASDAQHealthcareUS

$37.47

-0.95%

Market Cap: 4.8B

Compliance Status

Halal

Screened on Jul 16, 2026 · AAOIFI Standard 21

Very Good

82Score

Is 10x Genomics, Inc. (TXG) halal? Halal. Based on AAOIFI screening, 10x Genomics, Inc. passes both qualitative (business activity) and quantitative (financial ratio) screens with a compliance score of 82/100 (Grade: A).

AvoidBorderlineClean

Business activity

What the company sells is permissible.

Passed

Company debt

Well clear of the limit

How much the company borrows, compared to its total value. AAOIFI allows up to 30%.

2.7% of 30.0% limit

What this means for you

You can own TXG

It passes both the business activity and financial ratio screens under AAOIFI Standard 21.

Purify 2.4% of your income from TXG

That is about $2.40 of every $100 you earn from it. Donate this share to charity.

Calculate my exact amount

About 10x Genomics, Inc.

Headquartered in Pleasanton, California, 10x Genomics, Inc. (founded in 2012 and known as 10X Technologies, Inc. until November 2014) is a prominent life science technology company. The firm specializes in creating and distributing sophisticated instrumentation, essential consumables, and software designed for in-depth analysis of biological systems. Its market presence extends globally, covering North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company's offerings feature Chromium and Chromium Connect instruments, supported by indispensable items such as microfluidic chips, slides, and reagents. A significant portion of their portfolio focuses on single-cell solutions, leveraging their Chromium platforms. These allow for precise measurement of gene activity at the individual cell level (single cell gene expression), detailed assessment of immune cell function and their targets (single cell immune profiling), exploration of DNA's physical organization and epigenetic modifications (single cell Assay for Transposase Accessible Chromatin - ATAC), and the concurrent quantification of both genetic activity and epigenetic programming across tens of thousands of cells in a single experiment (single cell multiome ATAC + gene expression). Additionally, 10x Genomics offers the Visium spatial gene expression solution, which maps gene activity patterns within specific tissue sections and can also facilitate co-detection of gene expression and proteins when paired with immunofluorescence. Their varied customer base includes academic, governmental, biopharmaceutical, and biotechnology organizations, among others.

Sector: Healthcare · Industry: Medical - Healthcare Information Services

Shariah Compliance Status

AAOIFI Standard 21Updated Jul 16, 2026

Compliance History

Halalnow
since Jun 2026
Under Review
until the change above
Halal
until the change above

Tracked since May 2026. Updates automatically on each re-screen.

Fiscal: Q1 2026Data source: EDGAR

More Healthcare Stocks

JNJ

Johnson & Johnson

UNH

UnitedHealth Group Incorporated

B+

ABBV

AbbVie Inc.

PFE

Pfizer Inc.

LLY

Eli Lilly and Company

A+

MRK

Merck & Co., Inc.

B+

Free · No credit card required

Track TXG and 10,000+ stocks with AI insights

Create your free account to unlock AI-powered compliance analysis, track your portfolio, calculate purification, and get unlimited AAOIFI screening.

Get Started Free Browse Screener

10,000+ assets AAOIFI standards Free watchlist

Frequently Asked Questions

Is 10x Genomics, Inc. (TXG) halal to invest in?

Based on AAOIFI Standard 21 screening, 10x Genomics, Inc. (TXG) is rated Halal with a compliance grade of A (Very Good). It passes both the business activity screen (no primary involvement in prohibited sectors) and the quantitative financial ratio screen (debt, interest deposits, and prohibited income all below AAOIFI thresholds).

Why did 10x Genomics, Inc. get a A compliance rating?

10x Genomics, Inc. (TXG) received a grade of A (Very Good) based on three AAOIFI Standard 21 financial ratios: debt-to-market-cap of 2.7% (limit 30%); interest-bearing deposits of 4.6% (limit 30%); prohibited income of 2.38% (limit 5%). The grade reflects the margin of safety across all three ratios relative to their thresholds.

What could change 10x Genomics, Inc.'s Shariah verdict?

10x Genomics, Inc.'s verdict is re-evaluated at each annual re-screen. Three events could change it: (1) the debt-to-market-cap ratio crossing 30%, typically from new debt issuance or a major drop in share price; (2) interest-bearing deposits exceeding 30% of market cap; or (3) prohibited revenue (alcohol, gambling, conventional finance, etc.) exceeding 5% of total revenue. Verdict flips are tracked in the compliance history section above.

How often is 10x Genomics, Inc. re-screened for Shariah compliance?

10x Genomics, Inc. (TXG) is re-screened annually using the most recent full-year financial data from SEC filings. HalalScreener also triggers an on-demand re-screen whenever the stored data is more than 7 days old, ensuring the ratios reflect the latest available financial statements. Last screened: Jul 16, 2026.

Screened according to AAOIFI Standard No. 21 · For informational purposes only. Consult a qualified Islamic finance advisor before investing.

Disclaimer: This screening is for informational purposes only and does not constitute financial, legal, or religious advice. Compliance is evaluated using AAOIFI financial standards (debt, deposits, and prohibited income ratios) and publicly available data. Ethical, political, social, or environmental considerations are outside the scope of this screening. Individual scholars and methodologies may differ. Always consult a qualified Islamic finance advisor before making investment decisions.